Details of the Drug

General Information of Drug (ID: DMZDR43)

• Drug Name: ADL 018
• Synonyms: Omalizumab biosimilar

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 1	[1]

• Drug Type: Antibody
• Cross-matching ID: TTD ID: DV3E9U

References

• [1] Clinical pipeline report, company report or official report of Kashiv BioSciences